Publikationen 2013

  • Therapies for multiple sclerosis: translational achievements and outstanding needs. Haghikia A, Hohlfeld R, Gold R, Fugger L. Trends Mol Med. 2013 May;19(5):309-19.


  • An electrophysiological approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. Prochnow N, Gold R, Haghikia A. J Neuroimmunol. 2013 Nov 15;264(1-2):48-53.


  • The role of the immune system in Huntington´s disease. Ellrichmann G, Reick C, Saft C, Linker RA. Clin Dev Immunol. 2013;2013:541259.


  • Disease course and outcome of 15 monocentrically treazed natalizumab-associated progressive multifocal leukoencephalopathy patients. Dahlhaus S, Hoepner R, Chan A, Kleiter I, Adams O, Lukas C, Hellwig K, Gold R. J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1068-74.


  • Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. Ayzenberg I, Kleiter I, Schröder A, Hellwig K, Chan A, Yamamura T, Gold R.JAMA Neurol. 2013 Mar 1;70(3):394-7.


  • Review of laquinimod and its therapeutic potential in multiple sclerosis. Thöne J, Gold R. Expert Opin Pharmacother. 2013 Dec;14(18):2545-52.